Legacy Education is a for-profit, nationally accredited education company founded in 2009. It operates four educational institutions across six campuses in California and trains personnel for the most in-demand medical specialties, including nursing, diagnostic and cardiac sonography, MRI, surgical technology, and sterile processing.
Investment attractiveness factors:
• Proven operating leverage. Results for fiscal 3Q 2026 beat consensus: revenue grew 15.0% year over year to $21.4 million versus the expected $20.5 million, adjusted EBITDA increased 12.6% to $4.4 million, net income totaled $3.0 million with diluted EPS of $0.22. A key scalability indicator: educational services expense declined to 51.7% of revenue from 54.4% a year earlier. Over nine months, revenue rose 29.7% to $60.0 million, and adjusted EBITDA by 22.3% to $10.5 million.
• Multiplicative expansion of training capacity. Management announced plans to increase capacity by 1,200 to 1,500 students over a twelve- to twenty-four-month horizon, equivalent to 34% to 42% of the current student body of 3,550. The drivers are expanded campus space at High Desert Medical College in Lancaster and Temecula, the launch of surgical technology and sterile processing programs, and a signed letter of intent to open a branch outside California with potential for 600 to 800 students. A hybrid learning model refined at Contra Costa Medical Career College makes it possible to increase cohort sizes through rotation of instructional blocks without a proportional increase in capex.
• Regulatory recognition as a barrier to entry. In February 2026, Integrity College of Health received a six-year reaccreditation grant from ABHES, the maximum term awarded by the agency, and in April Contra Costa Medical Career College received a five-year reaccreditation from ACCET. The importance of these decisions goes beyond reputational impact: accreditation determines eligibility to participate in federal Title IV programs, timelines for approval of new programs, and the ability to open branch campuses. Maximum-term grants both reduce regulatory tail risk and shorten the path from program approval to actual student enrollment.
• Structural growth of the end market. The U.S. Bureau of Labor Statistics forecasts that healthcare and social assistance will be the fastest-growing industry segment through 2034, with a growth rate of 8.4%, while about 1.9 million job openings in medical occupations will be created each year. Short programs with verifiable wage outcomes and local, non-cyclical employer demand protect student enrollment from the weakness seen in demand for four-year higher-education programs.
Our fair value estimate is based on a 12.5x EV/EBITDA multiple over the next twelve months, implying a premium to comparable postsecondary education sector companies, justified by revenue growth around 15% and a net cash position.
Target price: $14,50